Hina Singh | Neuroscience | Best Researcher Award

Dr. Hina Singh | Neuroscience | Best Researcher Award 

University of California, Riverside | United States

Dr. Hina Singh, Ph.D., currently serves as an Assistant Project Scientist in the Division of Biomedical Sciences at the School of Medicine, University of California, Riverside, USA. Her research focuses on neuroHIV, neuroimmunology, and nanobiotechnology, with particular expertise in investigating the role of interferon signaling in HIV-associated neurocognitive disorders and methamphetamine-induced neurotoxicity. She possesses extensive experience in neuronal and microglial cell culture, molecular biology, and advanced microscopy techniques, alongside proficiency in nanoparticle synthesis and biosensor development. Dr. Singh’s scholarly contributions are reflected in 55 peer-reviewed publications, accumulating over 2,190 citations and an impressive h-index of 23, highlighting her significant impact in biomedical and nanoscience research. Her scientific journey spans diverse areas, including superparamagnetic iron oxide nanoparticles, gold nanoparticle-based biosensors, and the synthesis of biocompatible nanomaterials for therapeutic applications. She has also been actively involved in mentoring students and collaborating on interdisciplinary research projects bridging neurobiology and nanotechnology. A recipient of multiple international honors such as the Early Career Investigator Travel Award and President’s Scholarship, Dr. Singh continues to advance translational research aimed at understanding molecular mechanisms underlying neuroinflammation, viral neuropathogenesis, and neuroprotective therapeutic strategies.

Profile: Scopus | Orcid 

Featured Publications 

Singh, H., et al. (2025). Medical importance and pharmacokinetics of gold nanoparticles in the human body. Molecular Cancer.

Singh, H., et al. (2025). EphB2-mediated ephrin-B reverse signaling on microglia drives an anti-viral, but inflammatory and neurotoxic response associated with HIV. Journal of Neuroinflammation.

Singh, H., et al. (2025). Advanced nanomaterials for cancer therapy: Gold, silver, and iron oxide nanoparticles in oncological applications.

Singh, H., et al. (2025). Advances in precision oncology using patient-derived organoids and functional biomaterials.

Singh, H., et al. (2024). Interferon-β deficiency alters brain response to chronic HIV-1 envelope protein exposure in a transgenic model of NeuroHIV. Brain, Behavior, and Immunity.